Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review.
<h4>Introduction</h4>Analytic approaches to clinical validation of results from preclinical models are important in assessment of their relevance to human disease. This systematic review examined consistency in reporting of glioblastoma cohorts from The Cancer Genome Atlas (TCGA) or Chin...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0264740&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850163097572999168 |
|---|---|
| author | Beth Fitt Grace Loy Edward Christopher Paul M Brennan Michael Tin Chung Poon |
| author_facet | Beth Fitt Grace Loy Edward Christopher Paul M Brennan Michael Tin Chung Poon |
| author_sort | Beth Fitt |
| collection | DOAJ |
| description | <h4>Introduction</h4>Analytic approaches to clinical validation of results from preclinical models are important in assessment of their relevance to human disease. This systematic review examined consistency in reporting of glioblastoma cohorts from The Cancer Genome Atlas (TCGA) or Chinese Glioma Genome Atlas (CGGA) and assessed whether studies included patient characteristics in their survival analyses.<h4>Methods</h4>We searched Embase and Medline on 02Feb21 for studies using preclinical models of glioblastoma published after Jan2008 that used data from TCGA or CGGA to validate the association between at least one molecular marker and overall survival in adult patients with glioblastoma. Main data items included cohort characteristics, statistical significance of the survival analysis, and model covariates.<h4>Results</h4>There were 58 eligible studies from 1,751 non-duplicate records investigating 126 individual molecular markers. In 14 studies published between 2017 and 2020 using TCGA RNA microarray data that should have the same cohort, the median number of patients was 464.5 (interquartile range 220.5-525). Of the 15 molecular markers that underwent more than one univariable or multivariable survival analyses, five had discrepancies between studies. Covariates used in the 17 studies that used multivariable survival analyses were age (76.5%), pre-operative functional status (35.3%), sex (29.4%) MGMT promoter methylation (29.4%), radiotherapy (23.5%), chemotherapy (17.6%), IDH mutation (17.6%) and extent of resection (5.9%).<h4>Conclusion</h4>Preclinical glioblastoma studies that used TCGA for validation did not provide sufficient information about their cohort selection and there were inconsistent results. Transparency in reporting and the use of analytic approaches that adjust for clinical variables can improve the reproducibility between studies. |
| format | Article |
| id | doaj-art-7926f402075c473dbd74fb60f62a03e1 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-7926f402075c473dbd74fb60f62a03e12025-08-20T02:22:21ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01173e026474010.1371/journal.pone.0264740Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review.Beth FittGrace LoyEdward ChristopherPaul M BrennanMichael Tin Chung Poon<h4>Introduction</h4>Analytic approaches to clinical validation of results from preclinical models are important in assessment of their relevance to human disease. This systematic review examined consistency in reporting of glioblastoma cohorts from The Cancer Genome Atlas (TCGA) or Chinese Glioma Genome Atlas (CGGA) and assessed whether studies included patient characteristics in their survival analyses.<h4>Methods</h4>We searched Embase and Medline on 02Feb21 for studies using preclinical models of glioblastoma published after Jan2008 that used data from TCGA or CGGA to validate the association between at least one molecular marker and overall survival in adult patients with glioblastoma. Main data items included cohort characteristics, statistical significance of the survival analysis, and model covariates.<h4>Results</h4>There were 58 eligible studies from 1,751 non-duplicate records investigating 126 individual molecular markers. In 14 studies published between 2017 and 2020 using TCGA RNA microarray data that should have the same cohort, the median number of patients was 464.5 (interquartile range 220.5-525). Of the 15 molecular markers that underwent more than one univariable or multivariable survival analyses, five had discrepancies between studies. Covariates used in the 17 studies that used multivariable survival analyses were age (76.5%), pre-operative functional status (35.3%), sex (29.4%) MGMT promoter methylation (29.4%), radiotherapy (23.5%), chemotherapy (17.6%), IDH mutation (17.6%) and extent of resection (5.9%).<h4>Conclusion</h4>Preclinical glioblastoma studies that used TCGA for validation did not provide sufficient information about their cohort selection and there were inconsistent results. Transparency in reporting and the use of analytic approaches that adjust for clinical variables can improve the reproducibility between studies.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0264740&type=printable |
| spellingShingle | Beth Fitt Grace Loy Edward Christopher Paul M Brennan Michael Tin Chung Poon Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review. PLoS ONE |
| title | Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review. |
| title_full | Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review. |
| title_fullStr | Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review. |
| title_full_unstemmed | Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review. |
| title_short | Analytic approaches to clinical validation of results from preclinical models of glioblastoma: A systematic review. |
| title_sort | analytic approaches to clinical validation of results from preclinical models of glioblastoma a systematic review |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0264740&type=printable |
| work_keys_str_mv | AT bethfitt analyticapproachestoclinicalvalidationofresultsfrompreclinicalmodelsofglioblastomaasystematicreview AT graceloy analyticapproachestoclinicalvalidationofresultsfrompreclinicalmodelsofglioblastomaasystematicreview AT edwardchristopher analyticapproachestoclinicalvalidationofresultsfrompreclinicalmodelsofglioblastomaasystematicreview AT paulmbrennan analyticapproachestoclinicalvalidationofresultsfrompreclinicalmodelsofglioblastomaasystematicreview AT michaeltinchungpoon analyticapproachestoclinicalvalidationofresultsfrompreclinicalmodelsofglioblastomaasystematicreview |